Cumberland Pharmaceuticals (CPIX)
Develops ifetroban for rare-disease complications while retaining a life-sciences venture interest.
$6.90
Pre-market+0.37 (+5.67%)
At close$6.53(−0.46%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions34 holders · as of Mar 31, 2026 | 18.43% | 2.76M shares | |
| Insiders7 holders · as of Mar 20, 2026 | 41.20% | 6.17M shares | |
| Otherremainder | 40.37% | 6.05M shares |
14.98M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Institutions13F, as of Mar 31, 2026
34 holders · 2.76M shares · 7 new positions · 13 increased · 10 reduced · 6 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Ikarian Capital, LLC | 553.2K | 3.69% | −2.8K | May 15, 2026 |
| Renaissance Technologies LLC | 470.7K | 3.14% | −1.5K | May 14, 2026 |
| Vanguard Capital Management LLC | 361.8K | 2.41% | +361.8Knew | May 15, 2026 |
| Dimensional Fund Advisors LP | 276.4K | 1.84% | +4.1K | May 7, 2026 |
| Perceptive Advisors LLC | 197.0K | 1.31% | −144.1K | May 29, 2026 |
| Bridgeway Capital Management, LLC | 163.5K | 1.09% | 0 | May 15, 2026 |
| Boothbay Fund Management, LLC | 127.7K | 0.85% | −813 | May 15, 2026 |
| Geode Capital Management, LLC | 114.3K | 0.76% | +7.0K | May 15, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| A.J. Kazimi | 38.40% | 5.79M | 13G | Feb 9, 2026 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 1, 2025 | Kenneth Krogulskidirector | Purchase | 68 | $3.44 | 288,413 |
| Aug 4, 2025 | Kenneth Krogulskidirector | Purchase | 68 | $4.01 | 288,481 |
| Aug 5, 2025 | Kenneth Krogulskidirector | Purchase | 68 | $3.92 | 288,549 |
| Aug 6, 2025 | Kenneth Krogulskidirector | Purchase | 68 | $3.34 | 288,617 |
| Aug 7, 2025 | Kenneth Krogulskidirector | Purchase | 68 | $3.14 | 288,685 |
| Aug 8, 2025 | Kenneth Krogulskidirector | Purchase | 68 | $3.39 | 288,753 |
| Aug 11, 2025 | Kenneth Krogulskidirector | Purchase | 68 | $2.87 | 288,821 |
| Aug 12, 2025 | Kenneth Krogulskidirector | Purchase | 68 | $2.91 | 288,889 |
| Aug 13, 2025 | Kenneth Krogulskidirector | Purchase | 68 | $2.94 | 288,957 |
| Aug 14, 2025 | Kenneth Krogulskidirector | Purchase | 68 | $2.84 | 289,025 |
CongressHouse and Senate disclosures
Not reported.
